NEW HAVEN, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapeutics for serious underserved diseases, today announced that senior management will participate in a Fireside Chat at the Craig-Hallum Biotech Catalyst Conference on Thursday, October 22, 2026. Following the event, a replay will be accessible by visiting the “Events” section on the “Investors” page of
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
Quince Therapeutics (QNCX) has an average rating of buy and mean price target of $74.75, according t
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Ocugen Inc (OCGN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that it will host a virtual key opinion leader (KOL) event on Monday, September 28, 2026 from 12:30-2:00 PM ET. The event will feature PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham and Women's Hospital) and Paul Yu, MD, PhD (Massach
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced that senior management will participate in the following investor conferences in September 2026: Cantor Global Healthcare Conference: Fireside chat on Wednesday, September 9, 2026 at 2:45 p.m. ET H.C. Wainwright 28th Annual Global Inves
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.